Corporate/M&A
USA Guide 2024 : New Jersey
Band 2
Email address
[email protected]Contact number
+1 609 919 6600About
Provided by Morgan, Lewis & Bockius LLP
We work on a broad range of global mergers and acquisitions. Our team counsels sellers and buyers, investors and owners, boards of directors, and sources of financing and intermediaries, including private equity and venture capital funds. We help secure transaction financing, working with investment and commercial banks and other institutional lenders, and we advise entity-level decisionmakers, counseling boards, independent director committees, and management groups in myriad regulated and unregulated industries around the world. Our transactions have ranged in value from a few million dollars to more than $70 billion.
Our team can handle any issues arising from a merger, acquisition, or divestiture, whether environmental, labor, employment, and compensation matters or government contracts, regulatory obligations, intellectual property rights, and tax matters. We help clients negotiate purchase and divestiture agreements, tender offers, restructurings, joint ventures, spin-offs, leveraged buyouts, and public-to-private transactions, and acquire distressed assets. We also advise public company targets and would-be acquirers regarding implementing or overcoming takeover defense mechanisms.
Chambers Review
Morgan, Lewis & Bockius LLP possesses a strong group with an enviable life sciences, pharmaceutical and technology practice. It displays considerable strength in M&A and private equity transactions for a wide range of high profile medical device and pharmaceutical clients. It is particularly adept at brokering strategic collaboration agreements between pharma companies worldwide. The team is also able to advise on the full range of securities matters.
Notable Practitioners
Steven Cohen represents technology, pharmaceutical and hardware companies in a broad range of strategic transactions, including acquisitions, financing and restructuring. He is chair of the emerging business and technology practice.
Alan Leeds is experienced in the representation of pharmaceutical companies in acquisitions and strategic alliances.
David Glazer is popular among major companies in the pharmaceutical industry for his handling of partnership agreements and other collaboration deals.
"David is very thoughtful and available. He's a great advisor."
David Schwartz's experience includes advising pharmaceutical and biotech companies on M&A and a range of financing matters, including public offerings and loans.
"David is extremely practical and has a really good business mind. He's a great partner."
"He's responsive and gives great advice."
Benjamin Novak primarily represents emerging growth companies in the life sciences and technology spaces. He also counts private equity firms and venture capital funds among his clientele.
Ranked Lawyers at
Morgan, Lewis & Bockius LLP
New Jersey
Members
Provided by Morgan, Lewis & Bockius LLP